Results 181 to 190 of about 119,198,728 (316)

Valorization of bark extracts from Cerrado and Amazon species: phenolic characterization, antioxidant capacity, and photoprotective potential for circular bioeconomy applications

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract Tree bark remains an underexploited source of high‐value‐added phenolic compounds with potential circular bioeconomy applications. This work characterized bark extracts from two species of distinct Brazilian biomes, Stryphnodendron adstringens (Cerrado) and Myrcia eximia (Amazon), obtained with three solvents (ethanol, methanol and acetone ...
Mário Sérgio Lorenço, Danilo José Machado de Abreu, Elesandra da Silva Araujo, Uasmim Lira Zidanes, Laise de Jesus dos Santos, Denisse Concepción Vega Villarruel, Elisângela Elena Nunes Carvalho, Fábio Akira Mori   +7 more
wiley   +1 more source

Anti-Viral Treatment Eligibility and Treatment Uptake Among People With Chronic Hepatitis B in Australia: The REACH-B Study. [PDF]

J Viral Hepat
Hajarizadeh B, Nelson R, George J, Hanson J, Davies J, Martinello M, Brown T, Wong I, Hasan T, Mascarenhas L, O'Beirne J, Wade A, Capati M, Trotter G, Thomas S, Nash L, Cowie B, Allard N, Tu T, Tran L, Howard S, Monaghan R, Carter J, Tu E, Erratt A, Carson J, Dore GJ, Matthews GV, REACH‐B Study Group.   +28 more
europepmc   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Very low HDL cholesterol in infectious mononucleosis with hepatitis: a real-world evidence study. [PDF]

Atheroscler Plus
Ben-Dov IZ, Danoon A.
europepmc   +1 more source

Evaluating a virtual paediatric adverse drug reaction clinic

British Journal of Clinical Pharmacology, EarlyView.
Aims Adverse drug reactions (ADRs) are a common problem in paediatric health care. There is limited access to expertise in the evaluation and management of potential ADRs in children, limiting access to these services and creating delays in assessment and management.
Emily Hauck, Blanca Del Pozzo‐Magana, Michael Rieder   +2 more
wiley   +1 more source

Factors Associated with Vaccination Completeness and Knowledge About Hepatitis B Among Undergraduate Nursing Students in Northeastern Brazil: A Cross-Sectional Study. [PDF]

Vaccines (Basel)
Rodrigues de Macêdo DN, de Oliveira Martins BD, de Sousa LC, Silva EF, Silva JFT, de Medeiros GG, Mendes PN, Marques Carvalho MS, Caetano Lira JA, da Silva Gomes CN, Evangelista de Araújo TM, Magalhães RLB.   +11 more
europepmc   +1 more source

N‐acetylcysteine for non‐paracetamol‐induced acute liver failure in children: A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Non‐surgical treatment of acute liver failure (ALF) is primarily supportive and depends on the underlying cause. While N‐acetylcysteine (NAC) is proven effective in paracetamol‐induced ALF, its potential benefits in non‐paracetamol ALF for paediatric patients remain unclear.
Alise D. E. de Groot, Désanka M. Stoppels, Arno R. Bourgonje, Willemien F. J. Hof, Martin C. J. Kneyber, Daan J. Touw, Henkjan J. Verkade, Paola Mian   +7 more
wiley   +1 more source

Regulatory harmonization: Evolution, globalization and future directions

British Journal of Clinical Pharmacology, EarlyView.
Regulatory harmonization has become an increasingly important and accepted approach to streamline regulatory review processes and expedite access to safe, effective and high‐quality medicines globally. This review explores the evolution and current status of regulatory harmonization, convergence and reliance initiatives.
Orin Chisholm, Elaine Y. L. Blair, Christine Y. Lu   +2 more
wiley   +1 more source

Paediatric chronic hepatitis C and the global elimination gap: burden and trends from 1990 to 2023 in the Global Burden of Disease Study 2023. [PDF]

EClinicalMedicine
Hong SJ, Zhang X, Malik F, Goh Suk-Hui L, El-Shabrawi MHF, Ciocca M, Indolfi G, Hardikar W, Kelly D, Schwarz KB, Hartmann P.   +10 more
europepmc   +1 more source

Hepatitis

American Journal of Public Health and the Nations Health, 1958
openaire   +3 more sources